CG
ARKG icon

Cutler Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cutler Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$15K Sell
17,400
-335,300
-95% -$10.1M ﹤0.01% 1105
2023
Q4 		$132K Buy
352,700
+13,300
+4% +$362K 0.01% 923
2023
Q3 		$25K Buy
339,400
+300,600
+775% +$9.83M ﹤0.01% 1870
2023
Q2 		$54K Buy
38,800
+27,000
+229% +$849K 0.01% 1242
2023
Q1 		$5K Sell
11,800
-53,800
-82% -$1.67M ﹤0.01% 2685
2022
Q4 		$17K Sell
65,600
-22,900
-26% -$727K ﹤0.01% 2317
2022
Q3 		$91K Sell
88,500
-12,100
-12% -$444K 0.01% 1454
2022
Q2 		$71K Sell
100,600
-74,400
-43% -$2.6M 0.01% 1678
2022
Q1 		$128K Buy
175,000
+66,500
+61% +$3.17M 0.01% 1515
2021
Q4 		$200K Buy
108,500
+13,200
+14% +$913K 0.01% 1317
2021
Q3 		$180K Sell
95,300
-393,000
-80% -$33M 0.01% 1433
2021
Q2 		$3.08M Buy
488,300
+128,900
+36% +$11M 0.14% 153
2021
Q1 		$2.07M Sell
359,400
-49,500
-12% -$4.91M 0.1% 213
2020
Q4 		$3.01M Buy
408,900
+399,400
+4,204% +$31.8M 0.14% 143
2020
Q3 		$35K Buy
+9,500
New +$557K ﹤0.01% 2026

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Cutler Group's ARKG Position: Q1 2024 in Review

Cutler Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 73% in Q1 2024, selling an estimated $310K and leaving 3,899 shares worth $112K. The position accounts for 0.04% of the portfolio, ranked #419.

Cutler Group first reported a position in ARKG in Q3 2020 and has held it in 14 quarters since. The position peaked at $712K in Q1 2022. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Cutler Group held 3,899 shares of ARK Genomic Revolution ETF worth $112K as of Q1 2024.
  • Cutler Group sold 10,304 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $310K.
  • ARK Genomic Revolution ETF made up 0.04% of Cutler Group's portfolio in Q1 2024, its #419 holding.
  • Cutler Group first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 14 quarters since.
  • Cutler Group's ARK Genomic Revolution ETF position peaked at $712K in Q1 2022.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.